IL159674A0 - Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using such dna sequences - Google Patents

Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using such dna sequences

Info

Publication number
IL159674A0
IL159674A0 IL15967402A IL15967402A IL159674A0 IL 159674 A0 IL159674 A0 IL 159674A0 IL 15967402 A IL15967402 A IL 15967402A IL 15967402 A IL15967402 A IL 15967402A IL 159674 A0 IL159674 A0 IL 159674A0
Authority
IL
Israel
Prior art keywords
dna sequences
detecting
methods
gene transcription
transcription regulatory
Prior art date
Application number
IL15967402A
Other languages
English (en)
Original Assignee
Chromagenics Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP01202581A external-priority patent/EP1273666A1/en
Application filed by Chromagenics Bv filed Critical Chromagenics Bv
Publication of IL159674A0 publication Critical patent/IL159674A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL15967402A 2001-07-04 2002-06-14 Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using such dna sequences IL159674A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP01202581A EP1273666A1 (en) 2001-07-04 2001-07-04 Method of selecting a DNA sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity
US30319901P 2001-07-05 2001-07-05
PCT/NL2002/000390 WO2003004704A2 (en) 2001-07-04 2002-06-14 Method of selecting dna sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity
US10/190,312 US7192741B2 (en) 2001-07-04 2002-07-05 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using such DNA sequences

Publications (1)

Publication Number Publication Date
IL159674A0 true IL159674A0 (en) 2004-06-20

Family

ID=47915807

Family Applications (4)

Application Number Title Priority Date Filing Date
IL15967402A IL159674A0 (en) 2001-07-04 2002-06-14 Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using such dna sequences
IL159674A IL159674A (en) 2001-07-04 2004-01-01 DNA sequences that have the ability to regulate transcription and methods for detecting and using these sequences
IL193373A IL193373A (en) 2001-07-04 2008-08-11 Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using such dna sequences
IL193374A IL193374A (en) 2001-07-04 2008-08-11 Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using such dna sequences

Family Applications After (3)

Application Number Title Priority Date Filing Date
IL159674A IL159674A (en) 2001-07-04 2004-01-01 DNA sequences that have the ability to regulate transcription and methods for detecting and using these sequences
IL193373A IL193373A (en) 2001-07-04 2008-08-11 Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using such dna sequences
IL193374A IL193374A (en) 2001-07-04 2008-08-11 Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using such dna sequences

Country Status (22)

Country Link
US (9) US7192741B2 (no)
EP (8) EP1808488B1 (no)
JP (3) JP4500044B2 (no)
KR (2) KR100942116B1 (no)
CN (1) CN1266282C (no)
AT (8) ATE358183T1 (no)
AU (3) AU2002314629B2 (no)
BR (1) BRPI0210771B8 (no)
CA (2) CA2450020C (no)
CY (1) CY1107678T1 (no)
DE (8) DE60236331D1 (no)
DK (8) DK1808488T3 (no)
ES (8) ES2285630T3 (no)
HK (1) HK1068652A1 (no)
IL (4) IL159674A0 (no)
MX (1) MXPA03011801A (no)
NO (1) NO338477B1 (no)
NZ (1) NZ530218A (no)
PT (1) PT1600510E (no)
SG (1) SG143066A1 (no)
WO (1) WO2003004704A2 (no)
ZA (1) ZA200309599B (no)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60236331D1 (de) 2001-07-04 2010-06-17 Chromagenics Bv DNS-Sequenzen mit Anti-Repressor-Aktivität
WO2003106674A2 (en) 2002-06-14 2003-12-24 Chromagenics B.V. Means and methods for regulating gene expression
ES2362273T3 (es) 2002-06-14 2011-06-30 Chromagenics B.V. Método para la producción simultánea de múltiples proteínas; vectores y células para su uso en el mismo.
ES2442615T5 (es) 2002-07-18 2023-03-16 Merus Nv Producción recombinante de mezclas de anticuerpos
USRE47770E1 (en) 2002-07-18 2019-12-17 Merus N.V. Recombinant production of mixtures of antibodies
WO2004055215A1 (en) 2002-12-18 2004-07-01 Chromagenics B.V. A method for improving protein production
DE60312039T2 (de) 2002-12-20 2007-11-08 Chromagenics B.V. Mittel und methoden zur produktion eines proteins durch chromatin-öffner, die chromatin zugänglicher für transkriptionsfaktoren machen können
EP1639009B1 (en) 2003-05-30 2013-02-27 Merus B.V. Fab library for the preparation of a mixture of antibodies
US20100069614A1 (en) 2008-06-27 2010-03-18 Merus B.V. Antibody producing non-human mammals
DK1670925T3 (da) 2003-10-02 2013-07-08 Crucell Holland Bv Pakningsceller til rekombinat adenovirus
WO2005059149A2 (en) * 2003-12-12 2005-06-30 Chromagenics B.V. Improved protein production
DK1737971T3 (da) 2004-01-20 2017-11-13 Merus Nv Blandinger af bindingsproteiner
BRPI0512798A (pt) * 2004-07-08 2008-04-08 Chromagenics Bv molécula de ácido nucleico recombinante, célula, método para produzir uma proteìna de interesse, uso de uma seqüência de ácido nucleico tendo atividade anti-repressora, métodos para gerar uma célula hospedeira expressando dois polipeptìdios de interesse, e para expressar dois polipeptìdios de interesse
ATE459720T1 (de) * 2004-08-18 2010-03-15 Bayer Cropscience Ag Pflanzen mit erhöhter plastidär aktivität der stärkephosphorylierenden r3-enzyme
US8999667B2 (en) 2004-11-08 2015-04-07 Chromagenics B.V. Selection of host cells expressing protein at high levels
ES2384391T3 (es) * 2004-11-08 2012-07-04 Chromagenics B.V. Selección de células hospedantes que expresan proteína a altos niveles
US20060195935A1 (en) 2004-11-08 2006-08-31 Chromagenics B.V. Selection of host cells expressing protein at high levels
US8039230B2 (en) 2004-11-08 2011-10-18 Chromagenics B.V. Selection of host cells expressing protein at high levels
JP5291341B2 (ja) 2004-11-08 2013-09-18 クロマジェニックス ベー ヴェー タンパク質を高レベルで発現する宿主細胞の選定
US20100136616A1 (en) * 2004-11-08 2010-06-03 Chromagenics B.V. Selection of Host Cells Expressing Protein at High Levels
DE602005027407D1 (de) * 2004-11-18 2011-05-19 Univ Hiroshima Nat Univ Corp Verfahren und Kit zur Proteinexpression und Regelung der Expression wiederholter Sequenzen, die durch Genamplifikation und -transformierung gebildet werden
EP1996705B1 (en) 2006-03-20 2011-08-31 ChromaGenics B.V. Expression augmenting dna fragments, use thereof, and methods for finding thereof
US20080124760A1 (en) 2006-07-26 2008-05-29 Barbara Enenkel Regulatory Nucleic Acid Elements
CN101627123A (zh) * 2007-01-08 2010-01-13 米利波尔公司 消除基因扩增的高表达细胞系
WO2010147462A2 (en) 2009-06-15 2010-12-23 Cellagenics B.V. Novel stringent selectable markers
US8566596B2 (en) 2010-08-24 2013-10-22 Cisco Technology, Inc. Pre-association mechanism to provide detailed description of wireless services
US9650630B2 (en) 2010-09-01 2017-05-16 Cellagenics B.V. Nucleic acid fragments from a ribosomal protein promoter for enhancing gene expression
NZ630551A (en) 2012-04-20 2017-11-24 Merus Nv Methods and means for the production of ig-like molecules
AU2013285355A1 (en) 2012-07-06 2015-01-29 Genmab B.V. Dimeric protein with triple mutations
NZ630563A (en) 2012-09-27 2017-04-28 Merus Nv Bispecific igg antibodies as t cell engagers
US10417380B1 (en) 2013-12-31 2019-09-17 Mckesson Corporation Systems and methods for determining and communicating a prescription benefit coverage denial to a prescriber
US10489552B2 (en) 2014-02-14 2019-11-26 Mckesson Corporation Systems and methods for determining and communicating patient incentive information to a prescriber
RS61129B1 (sr) 2014-02-28 2020-12-31 Merus Nv Antitelo koje vezuje erbb-2 i erbb-3
US10844127B2 (en) 2014-02-28 2020-11-24 Merus N.V. Antibodies that bind EGFR and ErbB3
US10157262B1 (en) 2015-03-10 2018-12-18 Mckesson Corporation Systems and methods for determining patient financial responsibility for multiple prescription products
LT3115376T (lt) 2015-07-10 2018-11-12 Merus N.V. Antikūnai, kurie jungiasi su žmogaus cd3
MX2018004988A (es) 2015-10-23 2018-11-09 Merus Nv Moleculas de union que inhibe el crecimiento de cancer.
US11514137B1 (en) 2016-03-30 2022-11-29 Mckesson Corporation Alternative therapy identification system
US10999224B1 (en) 2017-02-01 2021-05-04 Mckesson Corporation Method and apparatus for parsing an electronic message and constructing multiple differently prioritized messages therefrom
BR112019020508A2 (pt) 2017-03-31 2020-08-04 Merus N.V. anticorpos biespecíficos de ligação a erbb-2 e erbb3 para utilização no tratamento de células que possuem um gene de fusão nrg1
JP2020530028A (ja) 2017-08-09 2020-10-15 メルス ナムローゼ フェンノートシャップ ＥＧＦＲ及びｃＭＥＴに結合する抗体
US10862832B1 (en) 2018-07-24 2020-12-08 Mckesson Corporation Computing system and method for automatically reversing an action indicated by an electronic message
US11043437B2 (en) 2019-01-07 2021-06-22 Applied Materials, Inc. Transparent substrate with light blocking edge exclusion zone
US11636548B1 (en) 2019-06-26 2023-04-25 Mckesson Corporation Method, apparatus, and computer program product for providing estimated prescription costs
US11562437B1 (en) 2019-06-26 2023-01-24 Mckesson Corporation Method, apparatus, and computer program product for providing estimated prescription costs
EP3772518A1 (en) 2019-08-07 2021-02-10 Merus N.V. Modified human variable domains
WO2021155369A1 (en) * 2020-01-31 2021-08-05 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods to identify genetic silencers and applications thereof
US11610240B1 (en) 2020-02-17 2023-03-21 Mckesson Corporation Method, apparatus, and computer program product for partitioning prescription transaction costs in an electronic prescription transaction
IL298394A (en) 2020-05-21 2023-01-01 Merus Nv Methods and means for producing ig-like molecules
US11587657B2 (en) 2020-09-04 2023-02-21 Mckesson Corporation Method, apparatus, and computer program product for performing an alternative evaluation procedure in response to an electronic message
CN113539357B (zh) * 2021-06-10 2024-04-30 阿里巴巴达摩院(杭州)科技有限公司 基因检测方法、模型训练方法、装置、设备及系统

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US719271A (en) * 1902-01-13 1903-01-27 Solomon P Smith Furnace.
US5610053A (en) 1993-04-07 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services DNA sequence which acts as a chromatin insulator element to protect expressed genes from cis-acting regulatory sequences in mammalian cells
US5972605A (en) * 1994-07-07 1999-10-26 Geron Corporation Assays for regulators of mammalian telomerase expression
CN1184506A (zh) * 1995-03-24 1998-06-10 盐野义制药株式会社 基因表达抑制相关性dna分子和新的蛋白质
DE19539493A1 (de) * 1995-10-24 1997-04-30 Thomae Gmbh Dr K Starker homologer Promotor aus Hamster
US5773695A (en) 1996-01-26 1998-06-30 North Carolina State University Plant nuclear scaffold attachment region and method for increasing gene expression in transgenic cells
US6037525A (en) * 1996-08-01 2000-03-14 North Carolina State University Method for reducing expression variability of transgenes in plant cells
US5888809A (en) 1997-05-01 1999-03-30 Icos Corporation Hamster EF-1α transcriptional regulatory DNA
CA2333852C (en) 1998-07-21 2007-05-29 Cobra Therapeutics Limited A polynucleotide comprising a ubiquitous chromatin opening element (ucoe)
WO2000009749A1 (en) * 1998-08-14 2000-02-24 Stichting Voor De Technische Wetenschappen Method of detecting a dna sequence, a dna sequence, a method of making a dna construct and the use thereof
US6800457B2 (en) 1998-09-22 2004-10-05 Bristol-Myers Squibb Company Expression vectors containing hot spot for increased recombinant protein expression in transfected cells
US6521419B1 (en) 1998-09-22 2003-02-18 Kanakaraju Koduri Expression vectors containing hot spot for increased recombinant protein expression in transfected cells
AU1128400A (en) 1998-10-22 2000-05-08 Medical College Of Georgia Institute, Inc. Long terminal repeat, enhancer, and insulator sequences for use in recombinant vectors
PT1210411E (pt) * 1999-08-25 2006-12-29 Immunex Corp Composições e métodos para cultura celular melhorada
US6586205B1 (en) 2000-02-11 2003-07-01 Millennium Pharmaceuticals, Inc. 43239 a novel GPCR-like molecule and uses thereof
AU2001238178A1 (en) 2000-02-11 2001-08-20 Millennium Pharmaceuticals, Inc. Seven-transmembrane proteins/g-protein coupled receptors
KR100996016B1 (ko) 2000-09-20 2010-11-22 밀리포어 코포레이션 폴리뉴클레오티드
EP1273666A1 (en) 2001-07-04 2003-01-08 Chromagenics B.V. Method of selecting a DNA sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity
DE60236331D1 (de) 2001-07-04 2010-06-17 Chromagenics Bv DNS-Sequenzen mit Anti-Repressor-Aktivität
ES2362273T3 (es) * 2002-06-14 2011-06-30 Chromagenics B.V. Método para la producción simultánea de múltiples proteínas; vectores y células para su uso en el mismo.
WO2003106674A2 (en) * 2002-06-14 2003-12-24 Chromagenics B.V. Means and methods for regulating gene expression
WO2004055215A1 (en) 2002-12-18 2004-07-01 Chromagenics B.V. A method for improving protein production
DE60312039T2 (de) 2002-12-20 2007-11-08 Chromagenics B.V. Mittel und methoden zur produktion eines proteins durch chromatin-öffner, die chromatin zugänglicher für transkriptionsfaktoren machen können

Also Published As

Publication number Publication date
US7659094B2 (en) 2010-02-09
US20070026498A1 (en) 2007-02-01
AU2007234619B2 (en) 2011-06-02
EP1404872A2 (en) 2004-04-07
IL193373A (en) 2010-12-30
CA2812799C (en) 2016-01-26
ZA200309599B (en) 2006-05-31
DK1829972T3 (da) 2010-09-13
EP1808488A3 (en) 2007-11-14
ATE343004T1 (de) 2006-11-15
DK1404872T3 (da) 2007-02-19
EP1808488A2 (en) 2007-07-18
NZ530218A (en) 2005-09-30
EP1842919A1 (en) 2007-10-10
US20070031935A1 (en) 2007-02-08
AU2002314629B2 (en) 2007-08-30
ES2348174T3 (es) 2010-11-30
EP1806407B1 (en) 2010-05-05
DK1845162T3 (da) 2010-08-16
AU2007234619A1 (en) 2007-12-13
AU2011202193A1 (en) 2011-06-02
US7736870B2 (en) 2010-06-15
DK1829971T3 (da) 2010-08-16
US7192741B2 (en) 2007-03-20
BRPI0210771B1 (pt) 2015-12-22
EP1829971B1 (en) 2010-05-05
US7655441B2 (en) 2010-02-02
ATE467682T1 (de) 2010-05-15
DK1806407T3 (da) 2010-08-16
ATE466942T1 (de) 2010-05-15
EP1829972B1 (en) 2010-05-12
DE60236331D1 (de) 2010-06-17
US20070031934A1 (en) 2007-02-08
DE60236332D1 (de) 2010-06-17
US20070026499A1 (en) 2007-02-01
DE60237048D1 (de) 2010-08-26
ATE474053T1 (de) 2010-07-15
DK1600510T3 (da) 2007-06-25
US20030199468A1 (en) 2003-10-23
US7736868B2 (en) 2010-06-15
EP1600510A2 (en) 2005-11-30
EP1829972A3 (en) 2007-10-24
US7951586B2 (en) 2011-05-31
ES2285630T3 (es) 2007-11-16
ATE466944T1 (de) 2010-05-15
CA2450020C (en) 2013-08-13
JP5014443B2 (ja) 2012-08-29
IL159674A (en) 2009-02-11
DE60236334D1 (de) 2010-06-17
CN1266282C (zh) 2006-07-26
ES2344071T3 (es) 2010-08-17
ES2344070T3 (es) 2010-08-17
JP2010131025A (ja) 2010-06-17
EP1404872B1 (en) 2006-10-18
DE60215502T2 (de) 2007-08-30
US7749733B2 (en) 2010-07-06
EP1845162A1 (en) 2007-10-17
ATE466943T1 (de) 2010-05-15
DK1842919T3 (da) 2010-08-16
DE60215502D1 (de) 2006-11-30
NO20040011L (no) 2004-03-03
EP1806407A3 (en) 2008-06-04
EP1845162B1 (en) 2010-05-05
CN1524128A (zh) 2004-08-25
EP1600510A3 (en) 2006-02-22
JP2004533262A (ja) 2004-11-04
JP2010131024A (ja) 2010-06-17
US20070031933A1 (en) 2007-02-08
PT1600510E (pt) 2007-06-25
WO2003004704A2 (en) 2003-01-16
US7736869B2 (en) 2010-06-15
DE60219221D1 (de) 2007-05-10
ES2274045T3 (es) 2007-05-16
US20070128717A1 (en) 2007-06-07
EP1842919B1 (en) 2010-05-05
HK1068652A1 (en) 2005-04-29
AU2011202193B2 (en) 2011-09-29
MXPA03011801A (es) 2005-03-07
KR20090037485A (ko) 2009-04-15
NO338477B1 (no) 2016-08-22
US7662591B2 (en) 2010-02-16
BR0210771A (pt) 2004-07-13
CY1107678T1 (el) 2013-04-18
EP1829972A2 (en) 2007-09-05
EP1829971A3 (en) 2008-06-04
SG143066A1 (en) 2008-06-27
EP1808488B1 (en) 2010-07-14
DE60219221T2 (de) 2008-01-03
ES2344074T3 (es) 2010-08-17
ES2344073T3 (es) 2010-08-17
ES2344072T3 (es) 2010-08-17
CA2450020A1 (en) 2003-01-16
BRPI0210771B8 (pt) 2021-05-25
JP4500044B2 (ja) 2010-07-14
KR100942117B1 (ko) 2010-02-12
JP5014444B2 (ja) 2012-08-29
WO2003004704A3 (en) 2003-10-16
EP1600510B1 (en) 2007-03-28
DE60236379D1 (de) 2010-06-24
KR20090037960A (ko) 2009-04-16
DE60236333D1 (de) 2010-06-17
KR100942116B1 (ko) 2010-02-12
CA2812799A1 (en) 2003-01-16
ATE466941T1 (de) 2010-05-15
US20070037256A1 (en) 2007-02-15
EP1806407A2 (en) 2007-07-11
IL193374A (en) 2010-12-30
EP1829971A1 (en) 2007-09-05
US20070031936A1 (en) 2007-02-08
ATE358183T1 (de) 2007-04-15
DK1808488T3 (da) 2010-10-18

Similar Documents

Publication Publication Date Title
IL193374A (en) Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using such dna sequences
DE60039037D1 (de) Methode zur direkten sequenzierung von nukleinsäuren
SE0003286D0 (sv) Method and kit for human identification
UA96421C2 (ru) Нуклеотидная последовательность, кодирующая инсектицидный белок
ATE533837T1 (de) Microginin-produzierende proteine und nukleinsäuren, einen microginin gen-cluster kodierend, sowie methoden zur herstellung von microgininen
FR2883298B1 (fr) Fragments d'acides nucleiques et methode de detection specifique par identification moleculaire de differentes especes de bacteries du genre acinetobacter
WO2004089982A3 (en) April variants and methods thereof
DE60036645D1 (de) Methoden zur identifizierung evolutionär signifikanter änderungen in polynukleotid- und polypeptidsequenzen in domestizierten pflanzen und tieren
DK2186898T3 (da) Blomstrings-induktion
DE602004019696D1 (de) Die multiple resistenz von pflanzen gegen phytopathogene und schädlinge induzierende proteine
TH71671A (th) วิธีการสำหรับการผลิตกรดแอล-กลูตามิก
DE50203158D1 (de) Dna-expressionskonstrukt zur behandlung von infektionen mit leishmaniose
DE60303257D1 (de) Substanzen, Sequenzen und Methoden zur Identifizierung epidemischer Methicillin-resistenter Staphylococcus aureus Stämme

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed